
    
      The aims of the study were :

      evaluate the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in
      patients receiving cytotoxic chemotherapy for solid tumors.

      assess the relevance of screening questions to detect risk factors of hepatitis B virus (HBV)
      and hepatitis C virus (HCV) and to analyze the patients with superior risk of viral
      reactivation
    
  